I am happy to announce that preparations are diligently underway to stage the 11th Congress of the Japanese Society for Regenerative Medicine under the theme of “Challenge for Innovation” in Yokohama City, Japan (Exhibition Hall D & Annex Hall of Pacifico Yokohama), for three days from June 12 (Tue.) to 14 (Thu.), 2012.
The Japanese Society for Regenerative Medicine has about 3,000 members and stages its congress once a year. With Japanese society faced by great social changes in this 21st century, medical care too is at a big turning point. Not only the medical world but society in general is showing strong interest in regenerative medicine as one of the hopeful fields of medicine of our time.
Ten years have passed since the foundation of the Society, and regenerative medicine based on somatic cells in various fields is in the clinical application stage. Moreover, the emergence of embryonic stem cells and induced pluripotent stem cells has added further impetus to practical applications of regenerative medicine. The Japanese Society for Regenerative Medicine looks at the development of these activities and their correlation with society as important topics.
Affront this backdrop, Osaka University will be organizing the 11th Congress of the Japanese Society for Regenerative Medicine at Pacifico Yokohama. Though we would normally stage our congress in the Osaka area, Yokohama was selected as the site because the International Society for Stem Cell Research (ISSCR) will be holding its first meeting ever in Japan under the chairmanship of Kyoto University’s own Dr. Shinya Yamanaka at Pacifico Yokohama in that same period, so concurrently staging our congress is viewed as a good way to enhance the international presence of the Japanese Society for Regenerative Medicine.
Regenerative medicine is a fusion of medicine, biology, scientific engineering and other disciplines, that takes an innovative approach to intractable diseases that cannot be cured by available means. To clinically apply new technologies such as these, testing and social infrastructure such as regulations require innovating, but a disconnect between clinical research and practical application in Japan has been pointed out. So that regenerative medicine can contribute to a healthy, long life society of tomorrow, I am hoping for extensive passionate discussions on a number of other themes, least of which R&D from basic to clinical research, close cooperation amongst industry, academia and government, social contributions and regenerative medicine from the perspective of international cooperation and international competitiveness.
I ask for your endorsement and understanding of importance of research in regenerative medicine, and I am looking forward to your application to attend the Congress.
Yoshiki Sawa
President, 11th Congress of the Japanese Society of Regenerative Medicine
Professor, Cardiovascular Surgery, Osaka University Graduate School of Medicine